Position in ZTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$44,984
+$16,378 QoQ
Shares Held
626
+158.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,144
of 1,408 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rakuten Securities, Inc. holds $507,039 across 7 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
12,784 | $443,221 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
626 | $44,984 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
21 | $11,378 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
32 | $3,550 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
11 | $1,853 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40 | $1,355 | |
| 7 | VTRS |
Viatris Inc
|
44 | $698 |
All Filings in ZTS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,984 | 626 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $28,606 | 242 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $22,018 | 175 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $70,818 | 484 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $71,269 | 457 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $73,598 | 447 | Shares | Defined | 2025-04-18 | |
| 2024-12-31 | $27,535 | 169 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $586 | 3 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $6,761 | 39 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $6,429 | 38 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $10,657 | 54 | Shares | Defined | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||